UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study

Diabetes care, 2019-12, Vol.42 (12), p.2220-2227

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk of new‐onset type 2 diabetes in 600 055 people after COVID‐19: A cohort study

Diabetes, obesity & metabolism, 2022-06, Vol.24 (6), p.1176-1179

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring

Diabetes care, 2018-11, Vol.41 (11), p.2265-2274

2018

Link zum Volltext

Verfügbarkeit prüfen

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Diabetologia, 2021-12, Vol.64 (12), p.2609-2652

2021

Link zum Volltext

Verfügbarkeit prüfen

Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia

Diabetes, obesity & metabolism, 2023-07, Vol.25 (7), p.1985-1994

2023

Link zum Volltext

Verfügbarkeit prüfen

Challenges Associated with Insulin Therapy in Type 2 Diabetes Mellitus

The American journal of medicine, 2014-10, Vol.127 (10), p.S11-S16

2014

Link zum Volltext

Verfügbarkeit prüfen

SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes

Diabetes (New York, N.Y.), 2022-03, Vol.71 (3), p.511-519

2022

Link zum Volltext

Verfügbarkeit prüfen

The past, present, and future of basal insulins

Diabetes/metabolism research and reviews, 2016-09, Vol.32 (6), p.478-496

2016

Link zum Volltext

Verfügbarkeit prüfen

Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes

Diabetes care, 2024-02, Vol.47 (5), p.e39

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study

Diabetes care, 2020-01, Vol.43 (1), p.161-168

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk of New-Onset Type 2 Diabetes Mellitus in 600,055 Persons after COVID-19: a cohort study

Diabetes, obesity & metabolism, 2022-02, Vol.24 (6), p.1176-1179

2022

Link zum Volltext

Verfügbarkeit prüfen

Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real‐world study of more than 30 000 patients in a US electronic health record database

Diabetes, obesity & metabolism, 2020-04, Vol.22 (4), p.622-630

2020

Link zum Volltext

Verfügbarkeit prüfen

Fixed-ratio combination therapy for type 2 diabetes: the top ten things you should know about insulin and glucagon-like peptide-1 receptor agonist combinations

Postgraduate medicine, 2018-05, Vol.130 (4), p.375-380

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes

Diabetes, obesity & metabolism, 2022-08, Vol.24 (8), p.1439-1447

2022

Link zum Volltext

Verfügbarkeit prüfen

Erratum. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532

Diabetes care, 2022-05, Vol.45 (5), p.1299-1299

2022

Link zum Volltext

Verfügbarkeit prüfen

Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532

Diabetes care, 2021-05, Vol.44 (5), p.e103-e104

2021

Link zum Volltext

Verfügbarkeit prüfen

Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures

Diabetes technology & therapeutics, 2019-06, Vol.21 (6), p.336

2019

Link zum Volltext

Verfügbarkeit prüfen

Demographic characteristics and acute complications among adults with type 1 diabetes: Comparison of two multicentre databases from Germany and the United States

Journal of diabetes and its complications, 2021-03, Vol.35 (3), p.107812-107812, Article 107812

2021

Link zum Volltext

Verfügbarkeit prüfen

Initial Clinical Evaluation of VC-01TM Combination Product—A Stem Cell–Derived Islet Replacement for Type 1 Diabetes (T1D)

Diabetes (New York, N.Y.), 2018-07, Vol.67 (Supplement_1)

2018

Link zum Volltext

Verfügbarkeit prüfen

Importance of diabetes management during the COVID-19 pandemic

Postgraduate medicine, 2021-11, Vol.133 (8), p.912-919

2021

Link zum Volltext

Verfügbarkeit prüfen

TIME TO GET SERIOUS ABOUT INSULIN TIMING

Endocrine practice, 2017-04, Vol.23 (4), p.503-505

Pettus, Jeremy

2017

Link zum Volltext

Verfügbarkeit prüfen

Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes

JCI insight, 2019-12, Vol.4 (24)

2019

Link zum Volltext

Verfügbarkeit prüfen

The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3

PloS one, 2018-01, Vol.13 (1), p.e0190579-e0190579

2018

Link zum Volltext

Verfügbarkeit prüfen

Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?

Diabetes care, 2024-05, Vol.47 (5), p.782

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(91)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(48)
Humans
(46)
Diabetes
(44)
Insulin
(39)
Endocrinology & Metabolism
(35)
Diabetes Mellitus
(33)
Adult
(24)
Hypoglycemia
(23)
Female
(21)
Male
(21)
Glucose
(20)
Middle Aged
(17)
Glucose Monitoring
(16)
Diabetes Mellitus, Type 1 - Drug Therapy
(15)
Blood Glucose
(13)
Type 1 Diabetes
(13)
Diabetes Mellitus, Type 1 - Blood
(12)
Diabetic Ketoacidosis
(11)
Ketoacidosis
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study

Risk of new‐onset type 2 diabetes in 600 055 people after COVID‐19: A cohort study

Clinical Implications of Real-time and Intermittently Scanned Continuous Glucose Monitoring

The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors

Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia

Challenges Associated with Insulin Therapy in Type 2 Diabetes Mellitus

SGLT2 Inhibition Increases Fasting Glucagon but Does Not Restore the Counterregulatory Hormone Response to Hypoglycemia in Participants With Type 1 Diabetes

The past, present, and future of basal insulins

Continuous Glucose Monitoring Time Below Range Predicts Impaired Epinephrine Response to Hypoglycemia in Patients With Type 1 Diabetes

Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study

Risk of New-Onset Type 2 Diabetes Mellitus in 600,055 Persons after COVID-19: a cohort study

Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real‐world study of more than 30 000 patients in a US electronic health record database

Fixed-ratio combination therapy for type 2 diabetes: the top ten things you should know about insulin and glucagon-like peptide-1 receptor agonist combinations

Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetes

Erratum. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532

Response to Comment on Gregory et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic's Impact in Type 1 and Type 2 Diabetes. Diabetes Care 2021;44:526-532

Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures

Demographic characteristics and acute complications among adults with type 1 diabetes: Comparison of two multicentre databases from Germany and the United States

Initial Clinical Evaluation of VC-01TM Combination Product—A Stem Cell–Derived Islet Replacement for Type 1 Diabetes (T1D)

Importance of diabetes management during the COVID-19 pandemic

TIME TO GET SERIOUS ABOUT INSULIN TIMING

Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes

The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type 2 diabetes: A patient-level meta-analysis of EDITION 2 and 3

Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?

Suchergebnisse filtern